Clal Biotechnology Industries Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was ILS 0.072 million compared to ILS 0.081 million a year ago. Revenue was ILS 39.05 million compared to ILS 5.21 million a year ago.

Net income was ILS 2.43 million compared to net loss of ILS 33.85 million a year ago. Basic earnings per share from continuing operations was ILS 0.02 compared to basic loss per share from continuing operations of ILS 0.14 a year ago. Basic earnings per share was ILS 0.02 compared to basic loss per share of ILS 0.22 a year ago.